InsidersTradesSigma
Explore the full insider trade history of Raphael Pharmaceutical Inc., a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €28.2m. The latest transaction was reported on 11 March 2025 (Attribution). Among the most active insiders: Pilo Shlomo. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations